Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totalling 273,600 shares, a drop of 12.5% from the May 31st total of 312,800 shares. Based on an average daily volume of 142,400 shares, the short-interest ratio is presently 1.9 days. Approximately 0.8% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital raised Viemed Healthcare to a “strong-buy” rating in a research report on Tuesday, May 7th.
Check Out Our Latest Analysis on Viemed Healthcare
Viemed Healthcare Stock Performance
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its quarterly earnings results on Monday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $50.59 million for the quarter. Viemed Healthcare had a return on equity of 9.32% and a net margin of 5.32%.
Hedge Funds Weigh In On Viemed Healthcare
Several hedge funds and other institutional investors have recently modified their holdings of the company. Kent Lake Capital LLC bought a new stake in Viemed Healthcare in the 1st quarter valued at about $5,557,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Viemed Healthcare in the first quarter valued at approximately $97,000. Vanguard Group Inc. raised its holdings in shares of Viemed Healthcare by 53.0% during the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after buying an additional 617,009 shares during the last quarter. Pinnacle Wealth Planning Services Inc. acquired a new position in shares of Viemed Healthcare during the first quarter worth approximately $135,000. Finally, Russell Investments Group Ltd. grew its holdings in Viemed Healthcare by 5.3% in the 1st quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock worth $1,386,000 after buying an additional 7,386 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Recommended Stories
- Five stocks we like better than Viemed Healthcare
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- What is the FTSE 100 index?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.